Bullfrog AI (NASDAQ:BFRG) CEO Vininder Singh Acquires 75,000 Shares of Stock

Bullfrog AI Holdings Inc. (NASDAQ:BFRG) CEO Vininder Singh bought 75,000 shares of Bullfrog AI stock in a transaction dated Tuesday, September 22nd. The stock was purchased at an average cost of $0.60 per share, for a total transaction of $45,000.00. Following the completion of the acquisition, the chief executive officer directly owned 2,442,446 shares of the company’s stock, valued at approximately $1,465,467.60. The trade was a 3.17% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Bullfrog AI Trading Up 21.7%

Shares of Bullfrog AI stock opened at $0.60 on Wednesday. The stock has a 50 day moving average of $0.56 and a 200 day moving average of $0.68. Bullfrog AI Holdings Inc. has a 12 month low of $0.43 and a 12 month high of $2.04. The firm has a market cap of $11.12 million, a PE ratio of -1.30 and a beta of -2.71.

Bullfrog AI (NASDAQ:BFRG) last posted its earnings results on Friday, August 14th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.04. The business had revenue of $0.22 million during the quarter, compared to analysts’ expectations of $0.21 million. As a group, equities research analysts forecast that Bullfrog AI Holdings Inc. will post -0.37 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Bullfrog AI stock. J. Safra Sarasin Holding AG acquired a new stake in shares of Bullfrog AI Holdings Inc. (NASDAQ:BFRG) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 113,720 shares of the company’s stock, valued at approximately $191,000. J. Safra Sarasin Holding AG owned about 0.90% of Bullfrog AI as of its most recent SEC filing. Institutional investors own 0.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Bullfrog AI from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, September 16th. Wall Street Zen upgraded Bullfrog AI from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. Finally, Zacks Research raised Bullfrog AI to a “hold” rating in a research note on Friday, June 26th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Bullfrog AI presently has an average rating of “Reduce”.

Bullfrog AI Company Profile

BullFrog AI Holdings, Inc is a biotechnology and technology company that applies artificial intelligence and machine learning to drug development and precision medicine. The company focuses on helping pharmaceutical, biotechnology and healthcare organizations analyze complex biomedical data and identify insights that may support research and clinical decision-making.

Its primary platform, bfLEAP, is designed to process and analyze large, multidimensional datasets, including clinical, genomic and other healthcare-related information.